AngioDynamics to Participate in the 5th Annual Craig-Hallum Institutional Investor Conference AngioDynamics to Participate in the 5th Annual Craig-Hallum Institutional Investor Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--May 19, 2008--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative

AngioDynamics Closes Acquisition of Oncobionic Company Will Now Move to Provide 20 IRE Systems to Soft Tissue Ablation Thought Leaders QUEENSBURY, N.Y.--(BUSINESS WIRE)--May 13, 2008--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists,

AngioDynamics to Participate in the 2008 Bank of America Healthcare Conference AngioDynamics to Participate in the 2008 Bank of America Healthcare Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--May 8, 2008--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by

First Human Use Demonstrates Effectiveness of Irreversible Electroporation Treatment Positive Results to Trigger AngioDynamics' Acquisition of Oncobionic QUEENSBURY, N.Y.--(BUSINESS WIRE)--April 24, 2008--AngioDynamics (NASDAQ:ANGO) today reported that the first human clinical use employing

Offers Subject to Auction Process and Approval of Diomed's Bankruptcy Court; Purchases Would Strengthen AngioDynamics' Position in the Varicose Vein Treatment Market

-- Sales Increase 52% to $40.7 Million<br>

-- Net Income (including settlement with Diomed) of $4.9 Million and EPS of $0.20<br>

-- Adjusted Income (Non GAAP) of $7.2 Million and Adjusted EPS (Non GAAP) of $0.30 Per Share<br>

-- Record Cash Flow from Operations of $9.9 Million During Quarter<br>

-- Conference Call Begins Today at 4:30 p.m. Eastern Time

AngioDynamics Announces Conference Call for Fiscal Third Quarter 2008 Financial Results QUEENSBURY, N.Y.--(BUSINESS WIRE)--March 19, 2008--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists, and surgeons for the minimally

Updates Fiscal 2008 Sales Guidance

Mitchell Accepts CEO Position of Start-Up Medical Device Company

Dr. Stephen Ash Presents Study Results at International Symposium on Endovascular Therapy

Court Denies Diomed Motion Against AngioDynamics QUEENSBURY, N.Y., Jan 17, 2008 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular

Novel Catheter Design Promises Enhanced Flow with Fewer Complications

Operating Income Increases 59% -- Net Income Grows 26% to $3.1 Million or $0.13 Per Share -- (Non GAAP) Adjusted Income Increases 140% to $7.3 Million or $0.30 Per Share -- Guidance Reaffirmed for Fiscal Year 2008 -- Conference Call Begins Today at 4:30 p.m. Eastern Time

AngioDynamics Announces Conference Call for Second Quarter FY08 Financial Results AngioDynamics Announces Conference Call for Second Quarter FY08 Financial Results QUEENSBURY, N.Y., Dec 20, 2007 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by

AngioDynamics Issues Radiofrequency Ablation Statement QUEENSBURY, N.Y., Dec 19, 2007 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and peripheral

AngioDynamics to Participate in the RBC Capital Markets 2007 Healthcare Conference AngioDynamics to Participate in the RBC Capital Markets 2007 Healthcare Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 6, 2007--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used

AngioDynamics to Present at 19th Annual Piper Jaffray Health Care Conference AngioDynamics to Present at 19th Annual Piper Jaffray Health Care Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Nov. 19, 2007--AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical devices used by

AngioDynamics to Present at the Canaccord Adams Cardiovascular Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Nov. 9, 2007--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer

Largest and Longest Study on Radiofrequency Ablation Study Published in the October Issue of Annals of Surgery

AngioDynamics Granted Summary Judgment Motion On Willfulness in VNUS Litigation AngioDynamics Granted Summary Judgment Motion On Willfulness in VNUS Litigation QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 29, 2007--AngioDynamics (NASDAQ:ANGO) today announced that its motion for summary judgment of no